Detalhe da pesquisa
1.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
2.
Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(5): 876-883, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31785375
3.
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(1): 189-196, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493541
4.
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1218-1224, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30708189
5.
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Blood
; 125(9): 1367-76, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25550361
6.
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.
J Natl Compr Canc Netw
; 15(9): 1091-1102, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874594
7.
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(6): 1030-1036, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899561
8.
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.
Blood
; 123(21): 3239-46, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687088
9.
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Blood
; 121(5): 745-51, 2013 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23197589
10.
Acute Lymphoblastic Leukemia, Version 2.2015.
J Natl Compr Canc Netw
; 13(10): 1240-79, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483064
11.
Acute myeloid leukemia, version 2.2013.
J Natl Compr Canc Netw
; 11(9): 1047-55, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24029121
12.
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
J Geriatr Oncol
; 14(8): 101623, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678052
13.
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
Haematologica
; 97(4): 579-85, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22102709
14.
NCCN Clinical Practice Guidelines Acute myeloid leukemia.
J Natl Compr Canc Netw
; 10(8): 984-1021, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878824
15.
Acute lymphoblastic leukemia.
J Natl Compr Canc Netw
; 10(7): 858-914, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773801
16.
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Transplant Cell Ther
; 28(6): 309.e1-309.e9, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247612
17.
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).
Blood
; 114(9): 1736-45, 2009 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19556425
18.
The use of ibrutinib in chronic lymphocytic leukemia.
Clin Adv Hematol Oncol
; 14(3): 154-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058026
19.
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
J Geriatr Oncol
; 12(4): 531-539, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059999
20.
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Blood Cancer Discov
; 2(5): 434-449, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514432